Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection. 2007

Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
Instituto de Microbiologia Professor Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-590, Brazil. marcio@micro.ufrj.br

Glucosylceramides (GlcCer) are involved in the regulation of Cryptococcus neoformans virulence. In the present study, we demonstrate that passive immunization with a monoclonal antibody to GlcCer significantly reduces host inflammation and prolongs the survival of mice lethally infected with C. neoformans, revealing a potential therapeutic strategy to control cryptococcosis.

UI MeSH Term Description Entries
D008805 Mice, Inbred A An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. Mouse, Inbred A,Inbred A Mice,Inbred A Mouse
D002554 Cerebrosides Neutral glycosphingolipids that contain a monosaccharide, normally glucose or galactose, in 1-ortho-beta-glycosidic linkage with the primary alcohol of an N-acyl sphingoid (ceramide). In plants the monosaccharide is normally glucose and the sphingoid usually phytosphingosine. In animals, the monosaccharide is usually galactose, though this may vary with the tissue and the sphingoid is usually sphingosine or dihydrosphingosine. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1st ed)
D003453 Cryptococcosis Fungal infection caused by genus CRYPTOCOCCUS. C gattii Infection,C neoformans Infection,C. gattii Infection,C. neoformans Infection,Cryptococcus Infection,Cryptococcus Infections,Cryptococcus gattii Infection,Torulosis,Cryptococcus neoformans Infection,C gattii Infections,C neoformans Infections,C. gattii Infections,C. neoformans Infections,Cryptococcoses,Cryptococcus gattii Infections,Cryptococcus neoformans Infections,Infection, C gattii,Infection, C neoformans,Infection, C. gattii,Infection, C. neoformans,Infection, Cryptococcus,Infection, Cryptococcus gattii,Infection, Cryptococcus neoformans,Infections, C gattii,Infections, C. neoformans,Toruloses
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000908 Antibodies, Fungal Immunoglobulins produced in a response to FUNGAL ANTIGENS. Fungal Antibodies
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000946 Antigens, Fungal Substances of fungal origin that have antigenic activity. Fungal Antigen,Fungal Antigens,Antigen, Fungal
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
April 1993, Proceedings of the National Academy of Sciences of the United States of America,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
March 1987, Infection and immunity,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
January 1990, Research in immunology,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
May 1996, Clinical and experimental immunology,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
December 2000, Infection and immunity,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
September 1999, The Journal of infectious diseases,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
March 1998, Infection and immunity,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
May 2001, Infection and immunity,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
October 1991, Hybridoma,
Marcio L Rodrigues, and Li Shi, and Eliana Barreto-Bergter, and Leonardo Nimrichter, and Sandra E Farias, and Elaine G Rodrigues, and Luiz R Travassos, and Joshua D Nosanchuk
March 2023, Science translational medicine,
Copied contents to your clipboard!